Homeostatic changes of the endocannabinoid system in Parkinson's disease

Novel Natural and Synthetic Ligands of the Endocannabinoid System

(2010) Lumir Hanus et al.   CURRENT MEDICINAL CHEMISTRY

CB1 Cannabinoid Receptors and their Associated Proteins

(2010) Allyn Howlett et al.   CURRENT MEDICINAL CHEMISTRY

Endocannabinoids as Regulators of Transient Receptor Potential (TRP)Channels: a Further Opportunity to Develop New Endocannabinoid-Based Therapeutic Drugs

(2010) V. Marzo et al.   CURRENT MEDICINAL CHEMISTRY

Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients

(2010) Valerio Pisani et al.   MOVEMENT DISORDERS

Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry

(2010) Alexxai V. Kravitz et al.   NATURE

The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic Transmission

(2010) Asami Tanimura et al.   NEURON

Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum

(2010) David M. Lovinger   NEUROPHARMACOLOGY

Endocannabinoid Signaling and Long-Term Synaptic Plasticity

(2009) Boris D. Heifets et al.   Annual Review of Physiology

The endocannabinoid system as a target for the treatment of motor dysfunction

(2009) Javier Fernández-Ruiz   BRITISH JOURNAL OF PHARMACOLOGY

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis

(2009) Dagmar Koethe et al.   BRITISH JOURNAL OF PSYCHIATRY

Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway

(2009) M. T. Viscomi et al.   JOURNAL OF NEUROSCIENCE

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

(2009) Maria C Rodriguez-Oroz et al.   LANCET NEUROLOGY

Biological fluid biomarkers in neurodegenerative parkinsonism

(2009) Michael Eller et al.   Nature Reviews Neurology

The blood–brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates—Evidence from in vivo neuroimaging studies

(2009) Arnar Astradsson et al.   NEUROBIOLOGY OF DISEASE

The Endocannabinoid System in Parkinsons Disease

(2008) Massimiliano Di Filippo et al.   CURRENT PHARMACEUTICAL DESIGN

TRPV1 Receptors in the Central Nervous System: Potential for Previously Unforeseen Therapeutic Applications

(2008) Vincenzo Marzo et al.   CURRENT PHARMACEUTICAL DESIGN

The Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases

(2008) Diego Centonze et al.   CURRENT PHARMACEUTICAL DESIGN

Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity

(2008) Louise Adermark et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

TRPV1 channels facilitate glutamate transmission in the striatum

(2008) Alessandra Musella et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

(2008) Mauro Maccarrone et al.   NATURE NEUROSCIENCE

Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease

(2008) Gianluigi Lunardi et al.   PARKINSONISM & RELATED DISORDERS